Digital
June 22-23, 2020

MarketsandMarkets Next Gen Microbiome and Probiotics Virtual Conference - ( Time Zone - Eastern Time Zone (EST)

Witness the major breakthroughs of microbiome, probiotics and prebiotics research along with their applications pertaining to challenges like medicinal data interpretation, investment and regulatory hurdles faced by the practitioners. The intersection between emerging technology and discovery with the context of consumer interest. Detect the non-identified dysbiosis, to discover the potential areas under study for investments in Gut and Skin microbiome and its role as a diagnostic tool of pharmaceutical discovery.

See the Post Show report of our inaugural event here

Join us at Gen-Next Probiotics and Microbiome Congress, 2020 to network with biotech, pharma, academicians and investors to exchange views and observe the most ingenious research and technologies. Witness the amalgamation of study focused on pharmaceutical and medicinal approaches of probiotics and the nutraceutical and consumer approaches along with the role of microbiome in clinical applications and preventative medicine.

WHAT TO EXPECT

Key Highlights

• Microbial Innovations
• Gut and Skin Microbiota
• Regulatory Issues
• Pediatrics and infant health
• Live Probiotic Technology
• Strain Identification
• Fecal Microbiota & Engineered Microbiome
• Commercialization and R&D Collaborations

Who should attend?

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations, Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the department of 

• Microbiome discovery
• Department of Biochemistry and Immunology
• Microbiome science
• Microbiology
• Biological Science
• Gut Biology

CONFERENCE AGENDA
EMERGING TECHNIQUES USED TO STUDY MICROBIOME AND FUTURE OF PROBIOTICS
BUSINESS COMMERCIALIZATION AND R&D COLLABORATIONS
CONFERENCE SPEAKERS
Speakers
Maya Ivanjesku
Maya Ivanjesku
Chief Scientific Officer, Dakota Biotech
Jacob Bak Holm
Jacob Bak Holm
Director, Scientific Operations, , Clinical Microbiomics, Denmark
Julie McDonald
Julie McDonald
Lecturer, Imperial College London
Kristin Wannerberger
Kristin Wannerberger
Director, R&D Alliance Management, Ferring Pharmaceuticals
Kareem Barghouti
Kareem Barghouti
Co-Founder, VastBiome
Yug Varma
Yug Varma
CEO, Phi Therapeutics
Nils Hijlkema
Nils Hijlkema
CCO , TenWise
Bogdan Zisu
Bogdan Zisu
Senior Process Engineer, Fluid Air, Australia
SPONSORS
Sponsors & Exhibitors
example-image

Microbiome Labs

example-image

Atlantia Clinical Trials

Speaking Partner
example-image

TenWise B.V.

example-image

FLUID AIR

example-image

bitBiome

example-image

Tecan

example-image

Metagenics

example-image

Microbiology International

example-image

Clinical Microbiomics

example-image

Computomics

example-image

Ixcela

PAST EVENT GALLERY